[Avant + Arrière] Kit de plaquette (céramique) de frein pour Ford Edge Mazda CX-9 CX-7 Lincoln MKX KCN-100028 1990-bmw-325ix Numéro de pièce: KBB-118145 KDA-100498

Name: [Avant + Arrière] Kit de plaquette (céramique) de frein pour Ford Edge Mazda CX-9 CX-7 Lincoln MKX KCN-100028 1990-bmw-325ix Numéro de pièce: KBB-118145 KDA-100498
Brand: ivancuevas.com
SKU: 52919917857
Price: 116.23 USD
Availability: InStock
Rating: 4.6534 (21 reviews)

SKU 52919917857 · ★ 4.7

EUR116.23EUR166.23

Pay in 4 interest-free payments of $29.06 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 14 - Nov 19

Harbor notes

Description

[Avant + Arrière] Kit de plaquette (céramique) de frein pour Ford Edge Mazda CX 9 CX 7 Lincoln MKX KCN 100028 1990 bmw 325ix Numéro de pièce: KBB 118145 KDA 100498 Numéro de pièce: KBB 118145 Numéro de pièce: K8F 101661 Pièces interchangeables OEM: 8377 8384 PF8377X SS8377X AD8377 QE8377X UP8377X D1258 1258 xCMX D1258 8378 8807 PF8378X SS8378X AD8378 QE8378X UP8378X D1259 1259 xCMX D1259 957 NB957 957B 2010 Lincoln MKX

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Frequently Asked Questions for [Avant + Arrière] Kit de plaquette (céramique) de frein pour Ford Edge Mazda CX-9 CX-7 Lincoln MKX KCN-100028 1990-bmw-325ix Numéro de pièce: KBB-118145 KDA-100498

What should I check when reading a translated product listing?

Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.

How can I make a useful comparison table for several products?

Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.

How can I check whether a purchase involves ongoing commitments?

Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.